Page last updated: 2024-10-26

etidronate and DDD MPGNII

etidronate has been researched along with DDD MPGNII in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
"A 56-yr-old male developed a systemic illness while receiving cyclical oral etidronate therapy for idiopathic osteoporosis."4.78Idiopathic polymyositis complicated by arthritis and mesangial proliferative glomerulonephritis: case report and review of the literature. ( Bhalla, AK; Frost, NA; Hall, CL; Maddison, PJ; Morand, EF, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frost, NA1
Morand, EF1
Hall, CL1
Maddison, PJ1
Bhalla, AK1

Reviews

1 review available for etidronate and DDD MPGNII

ArticleYear
Idiopathic polymyositis complicated by arthritis and mesangial proliferative glomerulonephritis: case report and review of the literature.
    British journal of rheumatology, 1993, Volume: 32, Issue:10

    Topics: Arthritis; Etidronic Acid; Glomerulonephritis, Membranoproliferative; Humans; Male; Middle Aged; Ost

1993